[Vaccination: What's new?]
Identifieur interne : 000023 ( Main/Exploration ); précédent : 000022; suivant : 000024[Vaccination: What's new?]
Auteurs : Ulrich Seybold [Allemagne]Source :
- Deutsche medizinische Wochenschrift (1946) [ 1439-4413 ] ; 2018.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Allemagne, Capsules bactériennes, Enfant, Facteurs sexuels, Femelle, Humains, Vaccin contre le zona, Vaccination (), Vaccination (tendances), Vaccination de masse (), Vaccination de masse (tendances), Vaccins antigrippaux (administration et posologie), Vaccins antiméningococciques (administration et posologie), Vaccins conjugués (administration et posologie), Vaccins contre les papillomavirus (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins antiméningococciques, Vaccins conjugués, Vaccins contre les papillomavirus.
- tendances : Vaccination, Vaccination de masse.
- Adolescent, Adulte, Allemagne, Capsules bactériennes, Enfant, Facteurs sexuels, Femelle, Humains, Vaccin contre le zona, Vaccination, Vaccination de masse.
English descriptors
- KwdEn :
- Adolescent, Adult, Bacterial Capsules, Child, Female, Germany, Herpes Zoster Vaccine, Humans, Influenza Vaccines (administration & dosage), Mass Vaccination (methods), Mass Vaccination (trends), Meningococcal Vaccines (administration & dosage), Papillomavirus Vaccines (administration & dosage), Sex Factors, Vaccination (methods), Vaccination (trends), Vaccines, Conjugate (administration & dosage).
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Meningococcal Vaccines, Papillomavirus Vaccines, Vaccines, Conjugate.
- chemical : Herpes Zoster Vaccine.
- methods : Mass Vaccination, Vaccination.
- trends : Mass Vaccination, Vaccination.
- Adolescent, Adult, Bacterial Capsules, Child, Female, Germany, Humans, Sex Factors.
Abstract
Vaccination practices in Germany are driven by scientific developments and a complex regulatory environment. Some important developments in 2018 are described here: Starting in 2018 only quadrivalent influenza vaccines will be used for the seasonal vaccination. Despite the availability of meningococcus ACWY and B vaccines and their use in other countries only the type C conjugate vaccine will be used for the routine vaccination of children. For the first time there is now an official recommendation to also vaccinate boys against HPV using either the bivalent or the nonavalent vaccine. After promising trial results a timely guideline for the use of the newly available adjuvanted subunit zoster vaccine is to be expected. Negative trial results mark a major setback for the development of a CMV vaccine. While only developed during the 2013 - 16 outbreak a highly effective Ebola vaccine is already being distributed to fight the current Congo outbreak.
DOI: 10.1055/a-0638-9282
PubMed: 30060278
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Vaccination: What's new?]</title><author><name sortKey="Seybold, Ulrich" sort="Seybold, Ulrich" uniqKey="Seybold U" first="Ulrich" last="Seybold">Ulrich Seybold</name><affiliation wicri:level="4"><nlm:affiliation>Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München.</nlm:affiliation><country>Allemagne</country><placeName><settlement type="city">Munich</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30060278</idno><idno type="pmid">30060278</idno><idno type="doi">10.1055/a-0638-9282</idno><idno type="wicri:Area/Main/Corpus">000025</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000025</idno><idno type="wicri:Area/Main/Curation">000025</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000025</idno><idno type="wicri:Area/Main/Exploration">000025</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Vaccination: What's new?]</title><author><name sortKey="Seybold, Ulrich" sort="Seybold, Ulrich" uniqKey="Seybold U" first="Ulrich" last="Seybold">Ulrich Seybold</name><affiliation wicri:level="4"><nlm:affiliation>Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München.</nlm:affiliation><country>Allemagne</country><placeName><settlement type="city">Munich</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation></author></analytic><series><title level="j">Deutsche medizinische Wochenschrift (1946)</title><idno type="eISSN">1439-4413</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Bacterial Capsules</term><term>Child</term><term>Female</term><term>Germany</term><term>Herpes Zoster Vaccine</term><term>Humans</term><term>Influenza Vaccines (administration & dosage)</term><term>Mass Vaccination (methods)</term><term>Mass Vaccination (trends)</term><term>Meningococcal Vaccines (administration & dosage)</term><term>Papillomavirus Vaccines (administration & dosage)</term><term>Sex Factors</term><term>Vaccination (methods)</term><term>Vaccination (trends)</term><term>Vaccines, Conjugate (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Allemagne</term><term>Capsules bactériennes</term><term>Enfant</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Vaccin contre le zona</term><term>Vaccination ()</term><term>Vaccination (tendances)</term><term>Vaccination de masse ()</term><term>Vaccination de masse (tendances)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antiméningococciques (administration et posologie)</term><term>Vaccins conjugués (administration et posologie)</term><term>Vaccins contre les papillomavirus (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Meningococcal Vaccines</term><term>Papillomavirus Vaccines</term><term>Vaccines, Conjugate</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Herpes Zoster Vaccine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins antiméningococciques</term><term>Vaccins conjugués</term><term>Vaccins contre les papillomavirus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Vaccination</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Vaccination</term><term>Vaccination de masse</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Mass Vaccination</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Bacterial Capsules</term><term>Child</term><term>Female</term><term>Germany</term><term>Humans</term><term>Sex Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Allemagne</term><term>Capsules bactériennes</term><term>Enfant</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Vaccin contre le zona</term><term>Vaccination</term><term>Vaccination de masse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Vaccination practices in Germany are driven by scientific developments and a complex regulatory environment. Some important developments in 2018 are described here: Starting in 2018 only quadrivalent influenza vaccines will be used for the seasonal vaccination. Despite the availability of meningococcus ACWY and B vaccines and their use in other countries only the type C conjugate vaccine will be used for the routine vaccination of children. For the first time there is now an official recommendation to also vaccinate boys against HPV using either the bivalent or the nonavalent vaccine. After promising trial results a timely guideline for the use of the newly available adjuvanted subunit zoster vaccine is to be expected. Negative trial results mark a major setback for the development of a CMV vaccine. While only developed during the 2013 - 16 outbreak a highly effective Ebola vaccine is already being distributed to fight the current Congo outbreak.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30060278</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4413</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>15</Issue><PubDate><Year>2018</Year><Month>08</Month></PubDate></JournalIssue><Title>Deutsche medizinische Wochenschrift (1946)</Title><ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation></Journal><ArticleTitle>[Vaccination: What's new?]</ArticleTitle><Pagination><MedlinePgn>1086-1089</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-0638-9282</ELocationID><Abstract><AbstractText>Vaccination practices in Germany are driven by scientific developments and a complex regulatory environment. Some important developments in 2018 are described here: Starting in 2018 only quadrivalent influenza vaccines will be used for the seasonal vaccination. Despite the availability of meningococcus ACWY and B vaccines and their use in other countries only the type C conjugate vaccine will be used for the routine vaccination of children. For the first time there is now an official recommendation to also vaccinate boys against HPV using either the bivalent or the nonavalent vaccine. After promising trial results a timely guideline for the use of the newly available adjuvanted subunit zoster vaccine is to be expected. Negative trial results mark a major setback for the development of a CMV vaccine. While only developed during the 2013 - 16 outbreak a highly effective Ebola vaccine is already being distributed to fight the current Congo outbreak.</AbstractText><CopyrightInformation>© Georg Thieme Verlag KG Stuttgart · New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seybold</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Impfungen: Was ist neu?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Med Wochenschr</MedlineTA><NlmUniqueID>0006723</NlmUniqueID><ISSNLinking>0012-0472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053061">Herpes Zoster Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525703">MenACWY</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022401">Meningococcal Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053918">Papillomavirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C039455">capsular polysaccharide, meningococcal group B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016667" MajorTopicYN="N">Bacterial Capsules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053061" MajorTopicYN="N">Herpes Zoster Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022401" MajorTopicYN="N">Meningococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053918" MajorTopicYN="N">Papillomavirus Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="INFLUENZA">Ab der Saison 2018/19 werden ausschließlich quadrivalente Influenzaimpfstoffe zum Einsatz kommen.</AbstractText><AbstractText Label="MENINGOKOKKEN">Auch nach Verfügbarkeit von jeweils 2 Präparaten für die MenACWY- und MenB-Impfung empfiehlt die Ständige Impfkommission (STIKO) diese nur bei spezifischen Immundefekten, für Kinder weiter nur die MenC-Impfung ab 12 Monaten. HPV: Die STIKO empfiehlt 2018/19 erstmals die HPV-Impfung auch für Jungen, jedoch weiter nicht für Erwachsene. Weiter keine Präferenz des nonavalenten Impfstoffs.</AbstractText><AbstractText Label="HERPES ZOSTER">Überzeugende Studiendaten für den seit Mai 2018 verfügbaren adjuvantierten Subunit-Zoster-Impfstoff lassen eine Stellungnahme der STIKO erwarten. CMV: Negative Studienergebnisse für die DNA-Vakzine ASP0113 bei Nieren- und Stammzelltransplantat-Empfängern bedeuten eine Verzögerung auf dem Weg zu einer CMV-Impfung.</AbstractText><AbstractText Label="EBOLA">Der erst im Rahmen des Ausbruchs 2013 – 2016 entwickelte rVSV-ZEBOV-Impfstoff wird bereits im aktuellen Ausbruch im Kongo eingesetzt.</AbstractText></OtherAbstract><CoiStatement>Teilnahme an Advisory Boards und Beratertätigkeit für ViiV Healthcare GmbH.Vortragshonorar MSD Sharp & Dohme GmbH.Diese Tätigkeiten jeweils nicht für den Bereich Impfstoffe.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30060278</ArticleId><ArticleId IdType="doi">10.1055/a-0638-9282</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Bavière</li><li>District de Haute-Bavière</li></region><settlement><li>Munich</li></settlement><orgName><li>Université Louis-et-Maximilien de Munich</li></orgName></list><tree><country name="Allemagne"><region name="Bavière"><name sortKey="Seybold, Ulrich" sort="Seybold, Ulrich" uniqKey="Seybold U" first="Ulrich" last="Seybold">Ulrich Seybold</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000023 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000023 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30060278
|texte= [Vaccination: What's new?]
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30060278" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |